Elon Musk’s Neuralink has officially installed its brain-chip interface (BCI) into a third human patient, and the individual shared a video this week detailing his experiences gaining control of external devices and regaining the ability to talk through the use of AI.
On Monday, X user Bradford G Smith shared a video detailing his experience as the third person in the world to receive the Neuralink BCI, and as the first non-verbal patient and the first with Amyotrophic Lateral Sclerosis (ALS) to receive the implant. In the video, Smith details how the BCI works, how it’s less limiting than his previous eye tracker technology, and how it has literally helped him regain his voice through AI.
“I am typing this with my brain,” Smith wrote. “It is my primary communication.”
The video, which he says is the first edited directly with a BCI, is narrated by an AI-generated version of his old voice. Prior to the BCI, he was also unable to leave the house using his eye tracker, as it made it difficult to communicate unless he was in dark or low-light settings.
The video also shows how he’s able to connect with external devices using the BCI, with a live shots of him controlling his computer using a cursor.
You can see the full update below, which runs a little under 10 minutes.
READ MORE ON NEURALINK: Elon Musk: over 1,000 humans with Neuralink implants in 2026 is feasible
The news follows Neuralink’s initial update with Brad and other initial BCI patients, as was shared in a post on the company’s website in February. In it, Brad also explained how groundbreaking it was to be able to communicate outside and see his son win a robotics award, along with being able to consider leaving the city area for the first time in half a decade:
The most significant thing that happened this week will sound strange to you: I got to use the computer on the porch, and it worked!!
I went to [my child’s] soccer game, and the referee thought I was sleeping. I was actually able to talk outside. I [am] actually thinking about traveling outside the [city] metro [for] the first time in 5 years.
Both of Neuralink’s studies focus on restoring autonomy to people who are paraplegic through the use of external devices. The company gained initial approval from the U.S. Food and Drug Administration (FDA) to install the first BCI in a human patient in May 2023, with Noland Arbaugh being the first, a patient named Alex being the second, and Brad being the third.
Neuralink opened its Patient Registry worldwide earlier this month, allowing participants to submit to take part in the company’s initial PRIME and CONVOY studies. The firm also announced plans to operate the PRIME study out of a second location in Miami, Florida in January, after an initial location was launched in Phoenix, Arizona.
Last week, it was reported by Bloomberg that Neuralink is currently targeting a $500 million funding round at a valuation of $8.5 billion. Meanwhile, Neuralink has also been constructing office buildings near Austin, Texas, which initially aimed to be completed in May 2025.
Neuralink human trial patient shares his progress
